|
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |
|
|
|
|||||||||
|
|||||||||||
|
J Am Coll Cardiol, 1997; 29:1206-1213 © 1997 by the American College of Cardiology Foundation |
Echocardiography and Cardiac Catheterization Laboratories, Dallas Veterans Administration Hospital, Texas 75216, USA.
OBJECTIVES: This study sought to examine the hemodynamic and autonomic dose response to digoxin. BACKGROUND: Previous studies have demonstrated an increase in contractility and heart rate variability with digitalis preparations. However, little is known about the dose-response to digoxin, which has a narrow therapeutic window. METHODS: Nineteen patients with moderate heart failure and a left ventricular ejection fraction < 0.45 were studied hemodynamically using echocardiography and blood pressure at baseline and after 2 weeks of low dose (0.125 mg daily) and 2 weeks of moderate dose digoxin (0.25 mg daily). Loading conditions were altered with nitroprusside at each study. Autonomic function was studied by assessing heart rate variability on 24-h Holter monitoring and plasma norepinephrine levels during supine rest. RESULTS: Low dose digoxin provided a significant increase in ventricular performance, but no further increase was seen with the moderate dose. Low dose digoxin reduced heart rate and increased heart rate variability. Moderate dose digoxin produced no additional increase in heart rate variability or reduction in sympathetic activity, as manifested by heart rate, plasma norepinephrine or low frequency/high frequency power ratio. In addition, we did not find that either low or moderate dose digoxin increased parasympathetic activity. CONCLUSIONS: We conclude that moderate dose digoxin provides no additional hemodynamic or autonomic benefit for patients with mild to moderate heart failure over low dose digoxin. Because higher doses of digoxin may predispose to arrhythmogenesis, lower dose digoxin should be considered in patients with mild to moderate heart failure.
This article has been cited by other articles:
|
|
 |
|
  A. Ahmed Digoxin and Reduction in Mortality and Hospitalization in Geriatric Heart Failure: Importance of Low Doses and Low Serum Concentrations J. Gerontol. A Biol. Sci. Med. Sci., March 1, 2007; 62(3): 323 - 329. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Ahmed, J. B. Young, and M. Gheorghiade The underuse of digoxin in heart failure, and approaches to appropriate use Can. Med. Assoc. J., February 27, 2007; 176(5): 641 - 643. [Full Text] [PDF]
|
|
|
|
 |
|
 L. Groban and J. Butterworth Perioperative management of chronic heart failure. Anesth. Analg., September 1, 2006; 103(3): 557 - 575. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Gheorghiade, D. J. van Veldhuisen, and W. S. Colucci Contemporary Use of Digoxin in the Management of Cardiovascular Disorders Circulation, May 30, 2006; 113(21): 2556 - 2564. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Ahmed, M. W. Rich, T. E. Love, D. M. Lloyd-Jones, I. B. Aban, W. S. Colucci, K. F. Adams, and M. Gheorghiade Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial Eur. Heart J., January 2, 2006; 27(2): 178 - 186. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Puli, D. Eterovi, D. Miri, L. Giunio, A. Lukin, and D. Fabijani Triggering of Ventricular Tachycardia by Meteorologic and Emotional Stress: Protective Effect of {beta}-Blockers and Anxiolytics in Men and Elderly Am. J. Epidemiol., December 1, 2004; 160(11): 1047 - 1058. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Gheorghiade, K. F. Adams Jr, and W. S. Colucci Digoxin in the Management of Cardiovascular Disorders Circulation, June 22, 2004; 109(24): 2959 - 2964. [Full Text] [PDF]
|
|
|
|
 |
|
 S. S. Rathore, J. P. Curtis, Y. Wang, M. R. Bristow, and H. M. Krumholz Association of Serum Digoxin Concentration and Outcomes in Patients With Heart Failure JAMA, February 19, 2003; 289(7): 871 - 878. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. F. Adams Jr, M. Gheorghiade, B. F. Uretsky, J. H. Patterson, T. A. Schwartz, and J. B. Young Clinical benefits of low serum digoxin concentrations in heart failure J. Am. Coll. Cardiol., March 20, 2002; 39(6): 946 - 953. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. van Veldhuisen Low-dose digoxin in patients with heart failure: Less toxic and at least as effective? J. Am. Coll. Cardiol., March 20, 2002; 39(6): 954 - 956. [Full Text] [PDF]
|
|
|
|
|
|
A. Nohria, E. Lewis, and L. W. Stevenson Medical Management of Advanced Heart Failure JAMA, February 6, 2002; 287(5): 628 - 640. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. W. Rich, F. McSherry, W. O. Williford, S. Yusuf, and for the Digitalis Investigation Group Effect of age on mortality, hospitalizations and response to digoxin in patients with heart failure: the DIG study J. Am. Coll. Cardiol., September 1, 2001; 38(3): 806 - 813. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. W. Rich Heart Failure in the 21st Century: A Cardiogeriatric Syndrome J. Gerontol. A Biol. Sci. Med. Sci., February 1, 2001; 56(2): 88M - 96. [Abstract] [Full Text]
|
|
|
|
 |
|
 L. L. Clark Perioperative Treatment of Congestive Heart Failure Seminars in Cardiothoracic and Vascular Anesthesia, November 1, 2000; 4(4): 223 - 235. [Abstract] [PDF]
|
|
|
|
|
|
M Galinier, A Pathak, J Fourcade, C Androdias, D Curnier, S Varnous, S Boveda, P Massabuau, M Fauvel, J.M Senard, et al. Depressed low frequency power of heart rate variability as an independent predictor of sudden death in chronic heart failure Eur. Heart J., March 2, 2000; 21(6): 475 - 482. [Abstract] [PDF]
|
|
|
|
|
|
P. J. Hauptman and R. A. Kelly Digitalis Circulation, March 9, 1999; 99(9): 1265 - 1270. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Nolan, P. D. Batin, R. Andrews, S. J. Lindsay, P. Brooksby, M. Mullen, W. Baig, A. D. Flapan, A. Cowley, R. J. Prescott, et al. Prospective Study of Heart Rate Variability and Mortality in Chronic Heart Failure : Results of the United Kingdom Heart Failure Evaluation and Assessment of Risk Trial (UK-Heart) Circulation, October 13, 1998; 98(15): 1510 - 1516. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. M. Shaw, B. Kaplan, and K. L. Brayman Prospective investigations of concentration–clinical response for immunosuppressive drugs provide the scientific basis for therapeutic drug monitoring Clin. Chem., February 1, 1998; 44(2): 381 - 387. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 No Benefit to High-Dose Digoxin Journal Watch Cardiology, June 13, 1997; 1997(613): 7 - 7. [Full Text]
|
|
|
|
 |
|
 DIGITALIS: MORE IS NOT NECESSARILY BETTER Journal Watch (General), May 27, 1997; 1997(527): 2 - 2. [Full Text]
|
|
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |
